| Quarterly Financials | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 49 | 33 | 52 | 36 | 51 | 88 |
| Expenses | 32 | 27 | 39 | 23 | 36 | 72 |
| EBITDA | 17 | 6 | 14 | 13 | 15 | 16 |
| Operating Profit % | 35 % | 19 % | 26 % | 35 % | 30 % | 18 % |
| Depreciation | 1 | 0 | 0 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 |
| Profit Before Tax | 16 | 5 | 12 | 11 | 14 | 14 |
| Tax | -1 | 2 | 3 | 6 | 3 | 5 |
| Net Profit | 17 | 4 | 9 | 5 | 11 | 8 |
| EPS in ₹ | 5.15 | 0.89 | 1.75 | 1.13 | 2.33 | 0.16 |
Anlon Healthcare
Anlon Healthcare
28.86
+2.62
(9.98%)
Market Cap
1,533.95 Cr
PE Ratio
41.25
Volume
7,00,18,561.00
Day High - Low
28.86 - 26.91
52W High-Low
27.48 - 10.37
There are 2 new updates from the company1 day ago
View
Key Fundamentals
Market Cap
1,533.95 Cr
EPS
6.11
PE Ratio
41.25
PB Ratio
6.09
Book Value
4.33
EBITDA
47.80
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
11.42
Debt to Equity
0.35
Actual
Company News
View All News
Anlon Healthcare finalizes pricing for share swap to acquire Apiqo Organics and Bizotic Lifescience. The floor price of ₹17.85 per share matches the valuer's fair value, ensuring compliance with SEBI ICDR regulations.
Anlon Healthcare AGM voting results submitted
Sep 05, 2026
Sep 05, 2026Anlon Healthcare submitted the voting results and scrutinizer's report for its 13th Annual General Meeting held on September 5, 2026. The meeting was conducted via video conferencing.
Anlon Healthcare Limited issued a corrigendum to its AGM notice to address exchange queries regarding its preferential share issue. The filing details the allotment of over 85.8 million shares at ₹17.85 each, raising approximately ₹1,533 crore.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,846.40 | #1 4,43,013.21 | 36.99 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 41.29 | |
9,352.00 | 2,48,266.22 | 85.61 | 11,067.00 | 13.95 | 2,568 | 65.50 | 61.40 | |
4,935.00 | 1,87,711.54 | 87.65 | 13,886.20 | 20.34 | 2,138 | 3.28 | 51.09 | |
1,162.30 | 1,16,954.58 | 25.23 | 27,657.90 | 17.64 | 5,026 | -34.90 | 56.20 | |
1,384.10 | 1,11,813.87 | 33.34 | 29,044.60 | 2.24 | 3,870 | -39.18 | 45.24 | |
2,006.50 | 1,08,322.22 | 100.00 | 6,867.80 | 22.01 | 890 | #1 123.93 | 66.38 | |
2,480.00 | 1,02,423.00 | 48.54 | 14,636.40 | 14.85 | 1,938 | 29.13 | 62.86 | |
1,211.00 | 1,01,078.42 | 31.52 | 35,058.60 | 3.90 | 4,158 | -69.10 | 61.71 | |
1,700.00 | 97,814.24 | 26.63 | 34,145.20 | 5.56 | 3,503 | 25.21 | 56.69 | |
2,135.00 | 97,619.15 | #1 17.46 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 45.93 |
Growth Rate
Revenue Growth
42.90 %
Net Income Growth
41.95 %
Cash Flow Change
-169.12 %
ROE
-55.23 %
ROCE
-31.22 %
EBITDA Margin (Avg.)
3.20 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2025 | 2026 |
| Total Assets | 181 | 374 |
| Fixed Assets | 23 | 58 |
| Current Assets | 159 | 308 |
| Capital Work in Progress | 0 | 0 |
| Investments | 1 | 1 |
| Other Assets | 158 | 315 |
| Total Equity & Liabilities | 181 | 374 |
| Current Liabilities | 60 | 108 |
| Non Current Liabilities | 41 | 12 |
| Total Equity | 80 | 255 |
| Reserve & Surplus | 41 | 177 |
| Share Capital | 40 | 53 |
Cash Flow
| Cash Flow | 2025 | 2026 |
| Net Cash Flow | -1 | 23 |
| Investing Activities | 2 | -36 |
| Operating Activities | -22 | -59 |
| Financing Activities | 19 | 118 |
Share Holding
| % Holding | Oct 2024 | Apr 2025 | Jun 2025 | Aug 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 70.26 % | 70.26 % | 52.68 % | 70.26 % | 52.68 % | 52.68 % | 52.68 % | 52.68 % |
| FIIs | 0.00 % | 0.00 % | 14.42 % | 0.00 % | 0.00 % | 0.23 % | 0.32 % | 1.67 % |
| DIIs | 0.00 % | 0.00 % | 4.35 % | 0.00 % | 2.83 % | 4.49 % | 4.60 % | 1.22 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 14.64 % | 0.00 % | 20.73 % | 23.58 % | 24.38 % | 26.19 % |
| Others | 29.74 % | 29.74 % | 13.92 % | 29.74 % | 23.75 % | 19.02 % | 18.02 % | 18.24 % |
| No of Share Holders | 109 | 131 | 9,125 | 135 | 9,126 | 11,412 | 12,484 | 34,671 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Nov 2025 |  Quarterly Result Announcement | NA | 11 Nov 2025 | 13.91 | 14.25 |
| 09 Feb 2026 | Quarterly Result Announcement | NA | 09 Feb 2026 | 12.12 | 12.61 |
| 24 Apr 2026 |  Bonus | 1:1 | 24 Apr 2026 | 12.16 | 14.38 |
| 24 Apr 2026 |  Split | 2:10 | 24 Apr 2026 | 11.11 | 14.38 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 13.89 | 14.25 |
| 30 Jul 2026 | Quarterly Result Announcement | NA | 30 Jul 2026 | 15.01 | 15.89 |
| 05 Sept 2026 |  Annual General Meeting | NA | 05 Sept 2026 | 14.47 | 15.68 |
Announcements
Announcement For Incorporation Of Foreign Subsidiary Of The Company1 day ago
1 day agoAnnouncement As Per Regulation 30 Of SEBI LODR.1 day ago
1 day agoClarification On Price Movement5 days ago
5 days agoClarification sought from Anlon Healthcare Ltd6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Credit Rating7 days ago
7 days agoShareholder Meeting / Postal Ballot-Outcome of AGMSep 07, 2026
Sep 07, 2026Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 05, 2026
Sep 05, 2026Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2026
Sep 05, 2026Anlon Healthcare Limited Has Informed The Exchange Regarding Corrigendum To Notice Of Annual General Meeting To Be Held On September 05 2026Aug 25, 2026
Aug 25, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 17, 2026
Aug 17, 2026Reg. 34 (1) Annual Report.Aug 14, 2026
Aug 14, 2026Notice Of 13Th Annual General Meeting Of Anlon Healthcare LimitedAug 14, 2026
Aug 14, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2026
Aug 14, 2026Corporate Action - Fixes Book Closure For Annual General MeetingAug 13, 2026
Aug 13, 2026Corporate Action Record Date Fixed For Annual General MeetingAug 13, 2026
Aug 13, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday August 13 2026Aug 13, 2026
Aug 13, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 13, 2026
Aug 13, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 12, 2026
Aug 12, 2026Board Meeting Intimation for Rescheduled/Postponement Of MeetingAug 11, 2026
Aug 11, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 08, 2026
Aug 08, 2026Closure of Trading WindowAug 06, 2026
Aug 06, 2026Board Meeting Intimation for Approve Notice Of 13Th Annual General Meeting Of The CompanyAug 06, 2026
Aug 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 06, 2026
Aug 06, 2026Announcement under Regulation 30 (LODR)-Investor PresentationAug 05, 2026
Aug 05, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2026
Aug 01, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2026
Jul 31, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2026
Jul 31, 2026Financial Results For The Quarter Ended June 30 2026Jul 30, 2026
Jul 30, 2026Board Meeting Outcome for Financial Results For The Quarter Ended June 30 2026Jul 30, 2026
Jul 30, 2026Board Meeting Intimation for Declaration Of Financial Results For The Quarter Ended June 30 2026Jul 27, 2026
Jul 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 20, 2026
Jul 20, 2026Announcement For Incorporation Of Subsidiary CompanyJul 11, 2026
Jul 11, 2026Announcement Of Incorporated Of Subsidiary Company Of Anlon Healthcare LimitedJul 09, 2026
Jul 09, 2026Disclosure Regarding Interview/Podcast Of Chairman & Managing Director With Sumit Mehrotra Former Senior Anchor @CnbcawaazJul 06, 2026
Jul 06, 2026Disclosure Regarding Interview Of Chairman & Managing Director With Money TVJul 01, 2026
Jul 01, 2026Board Meeting Outcome for Incorporation Of Subsidiaries Of Anlon Healthcare LimitedJul 01, 2026
Jul 01, 2026Closure of Trading WindowJun 30, 2026
Jun 30, 2026Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Invitation For TV Interview On NDTV Profit.Jun 11, 2026
Jun 11, 2026Intimation Regarding Media Interaction Of Chairman & Managing DirectorJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 03, 2026
Jun 03, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJun 03, 2026
Jun 03, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
May 30, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2026
May 30, 2026Considered Approved And Taken On Record Audited Financial Results For The Quarter And Year Ended 31St March 2026May 29, 2026
May 29, 2026Board Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 31 2026May 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 28, 2026
May 28, 2026Board Meeting Intimation for To Consider And Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 Along With The Auditors Report Thereon.May 23, 2026
May 23, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2026
May 13, 2026Updates On AcquisitionMay 08, 2026
May 08, 2026Technical Indicators
RSI(14)
Overbought 92.22
ATR(14)
Volatile 1.49
STOCH(9,6)
Neutral 78.52
STOCH RSI(14)
Overbought 100.00
MACD(12,26)
Bullish 0.96
ADX(14)
Very Strong Trend 54.18
UO(9)
Bearish 57.75
ROC(12)
Uptrend And Accelerating 68.64
WillR(14)
Overbought -10.20
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
